Statistics for Nurix Therapeutics, (id:6548 NRIX)


Valuation metrics

Market cap
1.62B
Enterprise value
1.48B
Trailing P/E (ttm)
-8.32
Forward P/E
-8.24
PEG ratio
-8.24
Price/Sales (ttm)
28.77
Price/Book (mrq)
4.08
Enterprise Value/Revenue
26.26
Enterprise Value/EBITDA
-7.95

Overview

Shares outstanding
70.84M
Float
57.48M
Shares short
9.46M
% Held by insiders
0.01%
% Held by institutions
0.98%
Average volume (10 days)
1.29M
Average volume (90 days)

Price summary

52-Week low
5.65
52-Week high
29.56
52-Week change
73.06%
Beta
2.20
50-Day moving average
24.55
200-Day moving average
18.60

Dividends and splits

Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date

Financials

Fiscal year
Fiscal year ends
November 30th, 2023
Most recent quarter (mrq)
August 31th, 2024
Profitability
Profit margin
0.00%
Operating margin
-433.83%
Operational effectiveness
Return on assets
-29.46%
Return on equity
-57.96%
Income statement
Revenue (ttm)
0.92
Revenue per share (ttm)
0.92
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-186,400,992.00
Net income to common (ttm)
-176,976,000.00
Diluted EPS (ttm)
-2.90
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
448.05M
Total cash per share (mrq)
6.32
Total debt (mrq)
27.14M
Total Debt/Equity (mrq)
7.20
Current ratio (mrq)
528.50%
Book value per share (mrq)
5.62
Cash flow
Cash flow statement
-97,144,000.00
Levered free cash flow (LFCF)
-56,771,000.00

CleverShares.com|
2024 ©

1.0.9092.25789